Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2001

View Archived Issues

Pilot study of thalidomide in myelodysplastic syndrome yields encouraging results

Mechanism of action of ecteinascidin 743 shown to involve nucleotide excision repair

Avasimibe lowers VLDL-C and triglycerides in patients with combined hyperlipidemia

AMPA receptor binding described for Lilly's LY-395153

Taisho and Yamanouchi form joint research agreement for new drug discovery

Patient recruitment for phase III trials of T-20 completed

Study of AVI BioPharma's third-generation antisense technology to begin

Atrix licenses Leuprogel Depot products in Australia and New Zealand

BioTransplant and Gambro enter distribution agreement for cell separation product line

New applications for irbesartan submitted in Europe and the U.S.

New radioligand for monitoring Parkinson's disease progression

E.C approves DepoCyte for treatment of lymphomatous meningitis

FDA advisory committee unanimously recommends approval of Baxter's Extraneal PD solution

European approval granted for Ketek, Aventis' first-in-class antibiotic

Seattle Genetics and Icos sign agreement for the MAb component of SGN-15

Scientists at Cubist synthesize new cyclic lipopeptides as antibacterial compounds

Selective CDK4 inhibitors for the treatment of proliferative diseases identified at Lilly

New orally active elastase inhibitors reported by Sanofi-Synthelabo

Cysteine protease inhibitors and their use described by Ono Pharmaceutical

University of Nebraska researchers disclose novel selective NMDA receptor modulating agents

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...